Evidence map›Paper›PMID 42346914›Full record

ArticleJournal of imaging2026

3D Deep Learning for Brain Tumor Segmentation and Survival Prediction: A Comprehensive Multi-Modal Analysis Using the BraTS2020 Dataset.

Vivek Sanker, Dhanya Mahesh, Zhikai Li, Alexander Thaller, Philip Heesen, Linda Liverani, David Wang, Maria Jose Cavagnaro, Ravi Teja Medikonda, Laura Prolo and 3 more

Abstract read
In one paragraph

Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vivek SankerDepartment of Neurosurgery, Stanford University, Stanford, CA 94304, USA.
Dhanya MaheshGeisel School of Medicine at Dartmouth College, Hanover, NH 03755, USA.
Zhikai LiDepartment of Clinical Neurosciences, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.ORCID 0009-0000-5137-1934
Alexander ThallerDepartment of Neurosurgery, Medical University of Graz, 8010 Graz, Austria.ORCID 0009-0000-9171-804X
Philip HeesenDepartment of Neurosurgery, University of Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-5090-4935
Linda LiveraniDepartment of Neurosurgery, Santa Clara Valley Medical Center, 751 S Bascom Avenue, San Jose, CA 95128, USA.ORCID 0000-0002-5210-3357
David WangFaculty of Medicine, University of Oslo, 0316 Oslo, Norway.ORCID 0009-0008-7040-703X
Maria Jose CavagnaroDepartment of Neurosurgery, Stanford University, Stanford, CA 94304, USA.
Ravi Teja MedikondaDepartment of Neurosurgery, Stanford University, Stanford, CA 94304, USA.
Laura ProloDepartment of Neurosurgery, Stanford University, Stanford, CA 94304, USA.ORCID 0000-0001-7737-8675
Harminder SinghDepartment of Neurosurgery, Stanford University, Stanford, CA 94304, USA.
John RatliffDepartment of Neurosurgery, Stanford University, Stanford, CA 94304, USA.ORCID 0000-0003-3452-1907
Atman DesaiDepartment of Neurosurgery, Stanford University, Stanford, CA 94304, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThree-dimensional deep learning offers promise for automated accurate brain tumor segmentation and survival prediction but requires robust validation across multiple MRI modalities to be effectively implemented in clinical practice.

methodsThis study presents a comprehensive 3D deep learning framework using 369 cases from the BraTS2020 dataset. A 3D U-Net architecture was developed for tumor segmentation utilizing combined imaging data and optimized for computational efficiency and memory. The final 3D U-Net model segmentations were used to build machine learning 6-month and 12-month survival classifiers. Segmentation models were evaluated using multiple metrics, including the Dice Similarity Coefficient, Hausdorff Distance, and Cohen's d. The classification models were evaluated using AUC-ROC and balanced accuracy.

resultsSegmentation achieved a modest, but promising, performance across 30 epochs and with 295 training patients, achieving the best mean validation Dice = 0.8388 and a final-epoch mean Dice of 0.8263. Survival classification with a hybrid clinical and imaging logistic regression showed promising results, with 12-month prediction achieving AUC = 0.746 and 69% accuracy. The top contributing features for the 12-month prediction classifier were extent of resection, T1 contrast-enhanced tumor median, and FLAIR tumor median.

conclusionsThis comprehensive framework demonstrates that a multi-modal approach provides meaningful performance gains, while segmentation-derived features show a promising ability to enable survival prediction.

Indexed as

3D deep learningbrain tumor segmentationgliomamedical image analysisneuro-oncologyradiomicssurvival prediction

Identifiers

PMID42346914
PMCPMC13301384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.